orpea (ORP:EN Paris)
orpea (ORP) Snapshot
|
Open
€35.16
|
Previous Close
€35.29
|
|
|
Day High
€35.68
|
Day Low
€35.16
|
|
|
52 Week High
05/21/13 - €35.68
|
52 Week Low
05/22/12 - €24.32
|
|
|
Market Cap
1.9B
|
Average Volume 10 Days
92.3K
|
|
|
EPS TTM
€1.83
|
Shares Outstanding
53.0M
|
|
|
EX-Date
07/26/13
|
P/E TM
19.4x
|
|
|
Dividend
€0.60
|
Dividend Yield
1.40%
|
Related News
orpea (ORP) Related Businessweek News
No Related Businessweek News Foundorpea (ORP) Details
ORPEA Société Anonyme operates long-term health care, post-acute care, and psychiatric care facilities in European Union. The company operates nursing homes and long-term care facilities in France, Belgium, Italy, and Spain; post-acute and rehabilitation care facilities in France; and general psychiatric clinics in France and Switzerland. Its care facilities provide care and support services to residents; and logistical and residential services, such as accommodation, meals, laundry, room cleaning, and various entertainment activities. The company’s multi-disciplinary post-acute and rehabilitation care facilities offer physical medicine and physical therapy; orthopaedic and trauma rehabilitation; haematology and oncology post-acute and rehabilitation care; geriatric post-acute and rehabilitation care; and other specialist services, such as care of chronic neurovegetative states and multi-functional medical services. Its psychiatric clinics provide services for the patients with acute mental pathologies, such as depression, bipolar disorders, obsessive compulsive disorder, panic disorder, generalized anxiety, social phobia, alcohol dependency, behavioral addictions, overuse syndromes, and some forms of psychotic disorders. The company operates a network of 410 facilities comprising 38,348 beds. ORPEA Société Anonyme was founded in 1989 and is headquartered in Puteaux, France.
orpea (ORP) Top Compensated Officers
orpea (ORP) Key Developments
ORPEA Société Anonyme announced sales results for the first quarter ended March 31, 2013. For the quarter, the company reported tTotal sales of EUR 384.5 million against EUR 336.5 million a year ago. The group to reiterate its targets for 2013 with considerable confidence: sales growth of 12% (EUR 1,600 million), growth in profit and cash flow, control of debt and all of this against a background of selective growth.
ORPEA Société Anonyme reported consolidated earnings results for the year ended December 31, 2012. For the year, the company reported revenues of EUR 1,429.1 million against EUR 1,234.1 million a year ago. EBITDAR was EUR 368.5 million against EUR 311.4 million a year ago. EBITDA was EUR 256.3 million against EUR 218.2 million a year ago. Recurring operating profit was EUR 193.7 million against EUR 163.2 million a year ago. Operating profit was EUR 222.2 million against EUR 190.0 million a year ago. Profit before tax was EUR 149.4 million against EUR 125.0 million a year ago. Attributable net profit was EUR 97.0 million against EUR 80.3 million a year ago. Revenues rose by 15.8% on the back of brisk organic growth (8.2%) and the contribution made by acquisitions, especially in international markets. Recurring operating profit performance was driven predominantly by the ramp-up in mature facilities, which produced higher margins than those of beds under development: mature beds now account for 79% of the total for the network, up from 65% at year-end 2011. Operating profit reflected a non-recurring gain after tax of EUR 28.5 million, compared with EUR 26.8 million in 2011 owing in particular to real estate disposals. Attributable net profit represents an increase of 20.8%, in spite of the unfavourable impact of the increased tax burden from 2012 (over EUR 6 million). Net debt stood at EUR 1,802 million, almost stable compared with its level at June 30, 2012. It is still mainly property-related (85%), secured by high-quality assets that are not very volatile. The board of the company at the Annual General Meeting will propose paying out a dividend of EUR 0.60 per share for the financial year 2012, compared with EUR 0.50 in the previous financial year. This dividend would represent a payout ratio of 33% of attributable net profit.
ORPEA Société Anonyme announced that they will report Q1, 2013 results on Apr 30, 2013
| Recently Viewed | |||
| ORP:FP | €35.62 EUR | +0.33 | |
| Company | Last | Change | |
| No competitor information is available for ORP. | |||
| View Industry Companies | |||
Industry Analysis
ORP
Industry Average
| Valuation | ORP | Industry Range |
| Price/Earnings | -- | Not Meaningful |
| Price/Sales | -- | Not Meaningful |
| Price/Book | -- | Not Meaningful |
| Price/Cash Flow | 11.4x |
|
| TEV/Sales | -- | Not Meaningful |
Post a JobJobs
- New York, NY |Posted: May 17
- San Francisco, CA | YelpPosted: May 02
- San Francisco, CA | YelpPosted: May 02
- Northglenn, CO | Office DepotPosted: Mar 01
Sponsored Financial Commentaries
Sponsored Links
To contact ORPEA, please visit www.orpea.com. Company data is provided by Capital IQ. Please use this form to report any data issues.
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.








